Stock 688266 SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

Equities

688266

CNE100003RP1

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-05-09 EDT 		5-day change 1st Jan Change
55.3 CNY -0.14% Intraday chart for Suzhou Zelgen Biopharmaceuticals Co.,Ltd. +0.36% +4.46%
04-19 Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-12 Suzhou Zejing Topical Vitiligo Cream Gets NMPA's Nod for Clinical Trials MT

Business Summary

Suzhou Zelgen Biopharmaceuticals Co Ltd is a China-based company mainly engaged in pharmaceutical manufacturing. The Company's main products include pharmaceuticals and pharmaceutical intermediates and raw materials. Its products are mainly applied in the fields of tumors, bleeding and blood diseases, immune inflammatory diseases and hepatobiliary diseases. The Company operates in the domestic market and overseas markets.

Number of employees: 867

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical
99.3 %
302 99.8 % 384 99.3 % +27.14%
Pharmaceutical Intermediates and Raw Materials
0.7 %
1 0.2 % 3 0.7 % +342.17%
Asset Licensing
0.0 %
- - 0 0.0 % -

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
302 100.0 % 386 100.0 % +27.83%

Managers

Managers TitleAgeSince
Hui Ping Lu FOU
 Founder 57 09-03-17
Ze Lin Sheng CEO
 Chief Executive Officer 64 09-03-17
Gang Huang DFI
 Director of Finance/CFO 53 18-12-31
Ji Sheng Wu BRD
 Director/Board Member 59 16-06-30
Wei Hao Ma IRC
 Investor Relations Contact 37 19-06-30
Qing Ping Gao SEC
 Corporate Secretary 47 09-06-30

Members of the board

Members of the board TitleAgeSince
Bing Hui Zhang BRD
 Director/Board Member 61 -
Ze Lin Sheng CEO
 Chief Executive Officer 64 09-03-17
Hui Ping Lu FOU
 Founder 57 09-03-17
Ji Sheng Wu BRD
 Director/Board Member 59 16-06-30
Ruyi He BRD
 Director/Board Member 63 19-01-31
Bin Hua Lü BRD
 Director/Board Member - 22-05-18
De Yu Li BRD
 Director/Board Member - 22-05-18
Yuan Qi Ren BRD
 Director/Board Member - 22-05-18
Bi Hui Yi CHM
 Chairman - 22-05-18
Meng Heng Zhang BRD
 Director/Board Member 48 22-12-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 264,708,186 141,104,405 ( 53.31 %) 0 53.31 %

Shareholders

NameEquities%Valuation
City of KunShan
5.968 %
10,031,760 5.968 % 75 M ¥
GF Fund Management Co., Ltd.
4.245 %
7,135,863 4.245 % 53 M ¥
Fullgoal Fund Management Co., Ltd.
3.398 %
5,712,884 3.398 % 43 M ¥
Shu Gang Liu
2.480 %
4,169,610 2.480 % 31 M ¥
Li Heng Zheng
1.869 %
3,142,000 1.869 % 23 M ¥
Shanghai Junhe Licheng Investment Management Center LP
1.785 %
3,000,000 1.785 % 22 M ¥
Minsheng Life Insurance Co., Ltd.
1.572 %
2,642,880 1.572 % 20 M ¥
Kunshan State Owned Asset Sup. & Administration Commission
1.513 %
2,543,040 1.513 % 19 M ¥
Penghua Fund Management Co., Ltd.
1.504 %
2,528,304 1.504 % 19 M ¥
HuaAn Fund Management Co., Ltd.
1.356 %
2,278,969 1.356 % 17 M ¥
NameEquities%Valuation
Ze Lin Sheng
51.38 %
49,636,620 51.38 % 370 M ¥
Ningbo Zeao Equity Investment Management LP
17.08 %
16,500,600 17.08 % 123 M ¥
Hui Ping Lu
13.01 %
12,565,440 13.01 % 94 M ¥
Ze Gi Jackie Sheng
12.72 %
12,285,540 12.72 % 92 M ¥
Jiangsu Ruihua Investment Holding Group Co. Ltd.
4.225 %
4,081,632 4.225 % 30 M ¥
Ningbo Jingchen Investment Partnership LP
4.042 %
3,904,740 4.042 % 29 M ¥

Company contact information

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

No. 209, Chenfeng Road Yushan Town

215300, Kunshan

+

http://www.zelgen.com
address Suzhou Zelgen Biopharmaceuticals Co.,Ltd.(688266)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
55.3 CNY
Average target price
64 CNY
Spread / Average Target
+15.73%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD. Stock Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
+4.46% 2.03B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.04% 695B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.60% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.68% 330B
ABBVIE INC. Stock AbbVie Inc.
+3.78% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.72% 239B
NOVARTIS AG Stock Novartis AG
+8.35% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-7.57% 198B
AMGEN INC. Stock Amgen Inc.
+8.60% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688266 Stock
  4. Company Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW